Care of late intrauterine fetal death and stillbirth: Green-top Guideline No. 55.
Journal
BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741
Informations de publication
Date de publication:
28 Oct 2024
28 Oct 2024
Historique:
medline:
29
10
2024
pubmed:
29
10
2024
entrez:
28
10
2024
Statut:
aheadofprint
Résumé
A combination of mifepristone and a prostaglandin preparation should usually be recommended as the first-line intervention for induction of labour (Grade B). A single 200 milligram dose of mifepristone is appropriate for this indication, followed by: 24
Identifiants
pubmed: 39467688
doi: 10.1111/1471-0528.17844
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Royal College of Obstetricians and Gynaecologists.
Références
Stillbirth (Definition) Act 1992. Available from: https://www.legislation.gov.uk/ukpga/1992/29. Accessed 7 Apr 2021
MBRRACE‐UK Perinatal Mortality Surveillance Reports. Available from: https://www.npeu.ox.ac.uk/mbrrace‐uk/reports. Accessed Jan 2020
Fretts RC. Etiology and prevention of stillbirth. Am J Obstet Gynecol. 2005;193:1923–1935.
Lamont K, Scott NW, Jones GT, Bhattacharya S. Risk of recurrent stillbirth: systematic review and meta‐analysis. BMJ. 2015;24:350.
Cronin RS, Li M, Thompson JMD, Gordon A, Raynes‐Greenow CH, Heazell AEP, et al. An individual participant data meta‐analysis of maternal going‐to‐sleep position, interactions with fetal vulnerability, and the risk of late stillbirth. EClinicalMedicine. 2019;10:49–57.
Flenady V, Koopmans L, Middleton P, Frøen JF, Smith GC, Gibbons K, et al. Major risk factors for stillbirth in high‐income countries: a systematic review and meta‐analysis. Lancet. 2011;377:1331–1340.
Muglu J, Rather H, Arroyo‐Manzano D, Bhattacharya S, Balchin I, Khalil A, et al. Risks of stillbirth and neonatal death with advancing gestation at term: a systematic review and meta‐analysis of cohort studies of 15 million pregnancies. PLoS Med. 2019;16:e1002838.
Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ. 2013;346:f108. https://doi.org/10.1136/bmj.f108
Bukowski R, Hansen NI, Willinger M, Reddy UM, Parker CB, Pinar H, et al. Fetal growth and risk of stillbirth: a population‐based case‐control study. PLoS Med. 2014;11(4):e1001633. https://doi.org/10.1371/journal.pmed.1001633
Stacey T, Thompson JM. Mitchell EA Maternal perception of fetal activity and late stillbirth risk: findings from the Auckland Stillbirth Study. Birth. 2011;38:311–316.
Escañuela Sánchez T, Meaney S, O’Donoghue K. Modifiable risk factors for stillbirth: a literature review. Midwifery. 2019;79:102539.
Sarmon KG, Eliasen T, Knudsen UB, Bay B. Assisted reproductive technologies and the risk of stillbirth in singleton pregnancies: a systematic review and meta‐analysis. Fertil Steril. 2021;116(3):784–792. https://doi.org/10.1016/j.fertnstert.2021.04.007
Moore KA. Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta‐analysis. Lancet Glob Health. 2017;5(11):e1101–e1112.
Gurol‐Urganci I, Jardine JE, Carroll F, Draycott T, Dunn G, Fremeaux A, et al. Maternal and perinatal outcomes of pregnant women with SARS‐CoV‐2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol. 2021;225(5):522.e1–522.e11.
Development guide.
Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323:334–336.
Platt LD, Manning FA, Murata Y, Keegan KA, Druzin ML, Socol ML, et al. Diagnosis of fetal death in utero by real‐time ultrasound. Obstet Gynecol. 1980;55(2):191–193.
Weinstein BJ, Platt LD. The ultrasonic appearance of intravascular gas in fetal death. J Ultrasound Med. 1983;2:451–454.
McCully JG. Gas in the fetal joints: a sign of intrauterine death. Obstet Gynecol. 1970;36:433–436.
Cohen M. Chapter 4 Stillbirth and Intrauterine growth retardation. The Pediatric and Perinatal Autopsy Manual.
Burden C, Male S, Fox R. Spurious fetal movement after late fetal death. Br J Midwifery. 2010;18(10):659.
Erlandsson K, Lindgren H, Davidsson‐Bremborg A, Rådestad I. Women's premonitions prior to the death of their baby in utero and how they deal with the feeling that their baby may be unwell. Acta Obstet Gynecol Scand. 2012;91:28–33.
Lalor JG, Begley CM, Devane D. Exploring painful experiences: impact of emotional narratives on members of a qualitative research team. J Adv Nurs. 2006;56:607–616.
McCreight BS. Perinatal loss: a qualitative study in Northern Ireland. Omega. 2008;57:1–19.
Buckman R. Communications and emotions. BMJ. 2002;325:672.
Hughes P, Turton P, Hopper E, Evans CD. Assessment of guidelines for good practice in psychosocial care of mothers after stillbirth: a cohort study. Lancet. 2002;360:114–118.
Siassakos D, Jackson S, Gleeson K, Chebsey C, Ellis A, Storey C, et al. All bereaved parents are entitled to good care after stillbirth: a mixed‐methods multicentre study (INSIGHT). BJOG. 2018;125:160–170.
RCOG patient information leaflet when your baby dies before birth. Available from: https://www.rcog.org.uk/en/patients/patient‐leaflets/when‐your‐baby‐dies‐before‐birth/. Accessed Feb 2020
National bereavement care pathway. Available from: https://nbcpathway.org.uk/pathways/stillbirth‐bereavement‐care‐pathway. Accessed Jan 2019
Rand CS, Kellner KR, Revak‐Lutz R, Massey JK. Parental behavior after perinatal death: twelve years of observations. Psychosom Obstet Gynaecol. 1998;19:44–48.
Fox R, Pillai M, Porter H, Gill G. The management of late fetal death: a guide to comprehensive care. Br J Obstet Gynaecol. 1997;104:4–10.
Tomlinson AJ, Martindale EA, Bancroft K, Heazell A. Improved management of stillbirth using a care pathway. Int J Health Gov. 2017;2018(23):18–13.
Muin DA, Haslacher H, Koller V, Kiss H, Scharrer A, Farr A. Impact of fetal maceration grade on risk of maternal disseminated intravascular coagulation after intrauterine fetal death ‐ A retrospective cohort study. Sci Rep. 2018;8:12742.
Parasnis H, Raje B, Hinduja IN. Relevance of plasma fibrinogen estimation in obstetric complications. J Postgrad Med. 1992;38:183–185.
Rådestad I, Steineck G, Nordin C, Sjögren B. Psychological complications after stillbirth – influence of memories and immediate management: population based study. BMJ. 1996;312:1505–1508.
Wagaarachchi PT, Ashok PW, Narvekar NN, Smith NC, Templeton A. Medical management of late intrauterine death using a combination of mifepristone and misoprostol. BJOG. 2002;109:443–447.
RCOG considering a caesarean patient information leaflet. Available from: https://www.rcog.org.uk/for‐the‐public/browse‐all‐patient‐information‐leaflets/considering‐a‐caesarean‐birth‐patient‐information‐leaflet/
Keag OE, Norman JE, Stock SJ. Long‐term risks and benefits associated with caesarean delivery for mother, baby, and subsequent pregnancies: systematic review and meta‐analysis. PLoS Med. 2018;15:e1002494.
Rådestad I, Nordin C, Steineck G, Sjögren B. A comparison of women's memories of care during pregnancy, labour and delivery after stillbirth or live birth. Midwifery. 1998;14:111–117.
Larsen S, Dobbin J, McCallion O, Eskild A. Intrauterine fetal death and risk of shoulder dystocia at delivery. Acta Obstet Gynecol Scand. 2016;95:1345–1351.
Gold K. Maternal complications associated with stillbirth delivery: a cross‐sectional analysis. J Obstet Gynaecol. 2016;36(2):208–212.
Wall‐Wieler E, Carmichael SL, Gibbs RS, Lyell DJ, Girsen AI, El‐Sayed YY, et al. Severe maternal morbidity among stillbirth and live birth deliveries in California. Obstet Gynecol Int. 2019;134:310–317.
Stocks LP, Rowland JS, Martindale EA, Heazell AE. The use of the birthing pool after a diagnosis of stillbirth. J Obstet Gynaecol. 2010;30:200–201.
Ponce G, de Leon R, Wing DA. Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy; a systematic review. Contraception. 2009;1(79):259–271.
Sharma D, Singhal SR, Poonam PA, Kunika. Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death: condensation ‐ misoprostol and mifepristone combination is more effective than misoprostol alone in the management of intrauterine death. Taiwan J Obstet Gynecol. 2011;50:322–325.
Chaudhuri P. Mifepristone and misoprostol compared with misoprostol alone for induction of labor in intrauterine fetal death: a randomized trial. J Obstet Gynaecol Res. 2015;41:1884–1990.
Agrawal A, Basnet P, Thakur A, Rizal P, Rai R. Induction of labor using misoprostol with or without mifepristone in intrauterine deat. J Nepal Med Assoc. 2014;52:785–790.
FIGO. FIGO mifepristone & misoprostol and misoprostol only dosing charts 2023. 2023. Available from: https://www.figo.org/figo‐mifepristone‐misoprostol‐and‐misoprostol‐only‐dosing‐charts‐2023#:~:text=An%20update%20from%20the%20widely,fetal%20demise%2C%20induction%20of%20labour%2C
NICE Evidence Summary ESUOM 11 Induction of labour in late intrauterine fetal death: vaginal misoprostol (after oral mifepristone). Available from: https://www.nice.org.uk/advice/esuom11/chapter/Key‐points‐from‐the‐evidence. Accessed Feb 2020
British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary (BNF) 58. London: BMJ Publishing Group Ltd and RPS Publishing; 2009.
Weeks A, Fiala C, editors. How to dilute 200 mcg of misoprostol in 200ml water. Misoprostol in obstetrics and gynaecology; 2010. http://misoprostol.org/File/about.php
Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Dias S, Jones LV, et al. Labour induction with prostaglandins: a systematic review and network meta‐analysis. BMJ. 2015;350:h217.
Perri JB, Burke A, Edelman AB. Interruption of nonviable pregnancies of 24‐28 weeks’ gestation using medical methods: release date June 2013 SFP guideline #20133. Contracepon. 2013;88:341–349.
Nakintu N. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intra uterine fetal death in Mulago Hospital, Uganda. Afr Health Sci. 2001;1:55–59.
Calder AA, Loughney AD, Weir CJ, Barber JW. Induction of labour in nulliparous and multiparous women: a UK, multicentre, open‐label study of intravaginal misoprostol in comparison with dinoprostone. BJOG. 2008;115:1279–1288.
Prager M, Eneroth‐Grimfors E, Edlund M, Marions L. A randomised controlled trial of intravaginal dinoprostone, intravaginal misoprostol and transcervical balloon catheter for labour induction. BJOG. 2008;115:1443–1450.
Dodd JM, Crowther CA. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2006;125:3–8.
Royal College of Obstetricians and Gynaecologists. Green‐top Guideline No. 55. Birth after previous caesarean birth. London: RCOG; 2015.
Boyle A, Preslar JP, Hogue CJ, Silver RM, Reddy UM, Goldenberg RL. Route of delivery in women with stillbirth; results from the Stillbirth Collaborative Research Network. Obstet Gynaecol. 2017;129:693–698.
Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines. Guidelines for vaginal birth after previous caesarean birth. Number 155 (Replaces guideline number 147), February 2005. Int J Gynaecol Obstet. 2005;89:319–331.
Bujold E, Blackwell SC, Gauthier RJ. Cervical Ripening and transcervical Foley catheter and the risk of uterine rupture. Obstet Gynaecol. 2004;103:18–23.
Pullen S, Golden MA, Cacciatore J. “I’ll never forget those cold words as long as I live”: parent perceptions of death notification for stillbirth. J Soc Work End Life Palliat Care. 2012;8:339–355.
Hollins Martin CJ, Robb Y. Women's views about the importance of education in preparation for childbirth. Nurse Educ Pract. 2013;13:512–518.
Flanagan PG, Westmoreland D, Stallard N, Stokes IM, Ovine EJ. Chlamydiosis in pregnancy. Br J Obstet Gynaecol. 1996;103:382–385.
Catanzarite V, Schibanoff JM, Chinn R, Mendoza A, Weiss R. Overwhelming maternal sepsis due to a gas‐forming Escherichia coli chorioamnionitis. Am J Perinatol. 1994;11:205–207.
Braun U, Bearth G, Dieth V, Corboz L. A case of disseminated intravascular coagulation (DIC) in a cow with endometritis and fetal death. Schweiz Arch Tierheilkd. 1990;132:239–245. Article in German.
Sitras V, Šaltytė Benth J, Eberhard‐Gran M. Obstetric and psychological characteristics of women choosing epidural analgesia during labour: a cohort study. PLoS One. 2017;1210:e0186564.
Wee MYK, Tuckey JP, Thomas PW, Burnard S. A comparison of intramuscular diamorphine and intramuscular pethidine for labour analgesia: a two‐centre randomised blinded controlled trial. BJOG. 2014;121:447–456.
Smith LA, Burns E, Cuthbert A. Parenteral opiods for maternal pain management in labour. Cochrane Database Syst Rev. 2019;6.
Lee JH, Peralta FM, Palatnik A, Gaupp CL, McCarthy RJ. Neuraxial labor analgesia is not an independent predictor of perineal lacerations after vaginal delivery of patients with intrauterine fetal demise. Int J Obstet Anesth. 2017;32:21–27.
Ashken T, West S. Regional anaesthesia in patients at risk of bleeding. BJA Educ. 2021;21:84–94.
FSRH clinical guideline contraception after pregnancy. Available from: https://www.fsrh.org/standards‐and‐guidance/documents/contraception‐after‐pregnancy‐guideline‐january‐2017/. Accessed 17 Aug 2022
Carroll K, Noble‐Carr D, Sweeney L, Waldby C. The “Lactation after infant death (AID) framework”: a guide for online health information provision about lactation after stillbirth and infant death. J Hum Lact. 2020;36(3):480–491.
Basile ML, Thorsteinsson EB. Parents’ evaluation of support in Australian hospitals following stillbirth. PeerJ. 2015;3:e1049.
Ellis A, Chebsey C, Storey C, Bradley S, Jackson S, Flenady V, et al. Systematic review to understand and improve care after stillbirth: a review of parents’ and healthcare professionals’ experiences. BMC Pregnancy Childbirth. 2016;16:16.
Downe S, Schmidt E, Kingdon C, Heazell AE. Bereaved parents’ experience of stillbirth in UK hospitals: a qualitative interview study. BMJ Open. 2013;3:e002237.
Peters MDJ, Lisy K, Riitano D, Jordan Z, Aromataris E. Caring for families experiencing stillbirth: evidence‐based guidance for maternity care providers. Women Birth. 2015;28:272–278.
Spitz AM, Lee NC, Peterson HB. Treatment for lactation suppression: little progress in one hundred years. Am J Obstet Gynecol. 1998;179:1485–1490.
European Multicentre Study Group for Cabergoline in Lactation Inhibition. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. BMJ. 1991;302:1367–1371.
British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary (BNF) 54. London: BMJ Publishing Group Ltd and RPS Publishing; 2007.
Iffy L, Zito GE, Jakobovits AA, Ganesh V, McArdle JJ. Postpartum intracranial haemorrhage in normotensive users of bromocriptine for lactation. Pharmacoepidemiol Drug Saf. 1998;7:167–171.
Niebyl JR, Bell WR, Schaaf ME, Blake DA, Dubin NH, King TM. The effect of chlorotrianisene as postpartum lactation suppression on blood coagulation factors. Am J Obstet Gynecol. 1979;134:518–522.
AlSaad D, ElSalem S, Abdulrouf PV, Thomas B, Alsaad T, Ahmed A, et al. A retrospective drug use evaluation of cabergoline for lactation inhibition at a tertiary care teaching hospital in Qatar. Ther Clin Risk Manag. 2016;12:155–160.
Oladapo OT, Fawole B. British medical association and royal pharmaceutical society of Great Britain. Cochrane Database Syst Rev. 2012;(9):CD005937. https://doi.org/10.1002/14651858.CD005937.pub3
Rybstein MD. Risk factors for and clinical management of venous thromboembolism during pregnancy. Clin Adv Hematol Oncol. 2019;17:396–404.
Sultan AA, Tata LJ, West J, Fiaschi L, Fleming KM, Nelson‐Piercy C, et al. Risk factors for first venous thromboembolism around pregnancy: a population‐based cohort study from the United Kingdom. Blood. 2013;12119:3953–3961.
Royal College of Obstetricians and Gynaecologists. RCOG green‐top guideline No. 37a. reducing the risk of venous thromboembolism during pregnancy & puerperium. London: RCOG; 2015.
Engmann C, Garces A, Jehan I, Ditekemena J, Phiri M, Mazariegos M, et al. Causes of community stillbirths and early neonatal deaths in low‐income countries using verbal autopsy: an International, multicenter study. J Perinatol. 2012;32:585–592.
Wojcieszek AM, Shepherd E, Middleton P, Middleton P, Gardener G, Ellwood DA, et al. Interventions for investigating and identifying the causes of stillbirth. Cochrane Database Syst Rev. 2018a;4:CD012504. https://doi.org/10.1002/14651858.CD012504
Tsakiridis I, Giouleka S, Mamopoulos A, Athanasiadis A, Dagklis T. Investigation and management of Stillbirth: a descriptive review of major guidelines. J Perinat Med. 2022;50:796–813. https://doi.org/10.1515/jpm‐2021‐0403
Beune IM, Damhuis SE, Ganzevoort W, Hutchinson JC, Khong TY, Mooney EE, et al. Consensus definition of fetal growth restriction in intrauterine fetal death: a Delphi procedure. Arch Pathol Lab Med. 2021;145:428–436.
Vergani P, Cozzolino S, Pozzi E, Cuttin MS, Greco M, Ornaghi S, et al. Identifying the causes of stillbirth: a comparison of four classification systems. Am J Obstet Gynecol. 2008;199(319):e1–e4.
Gardosi J, Kady SM, McGeown P, Francis A, Tonks A. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ. 2005;331:1113–1117.
International Stillbirth Alliance Collaborative for Improving Classification of Perinatal Deaths, Flenady V, Wojcieszek AM, Ellwood D, Leisher SH, Erwich JJHM, et al. Classification of causes and associated conditions for stillbirths and neonatal deaths. Semin Fetal Neonatal Med. 2017;22(176):185.
Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48:333–339.
Page JM, Christiansen‐Lindquist L, Thorsten V, Parker CB, Reddy UM, Dudley DJ, et al. Diagnostic tests for evaluation of stillbirth: results from the stillbirth collaborative research network. Obstet Gynecol. 2017;129:699–706.
Korteweg FJ, Erwich JJHM, Folkeringa N, Timmer A, Veeger NJGM, Ravisé JM, et al. Prevalence of parental thrombophilic defects after fetal death and relation to cause. Obstet Gynecol. 2010;116:355–364.
Arachchillage DJ, Mackillop L, Chandratheva A, Motawani J, MacCallum P, Laffan M. Thrombophilia testing: a British society for haematology guideline. Br J Haematol. 2022;198:443–458.
Moyo SR, Tswana SA, Nyström L, Bergström S, Blomberg J, Ljungh A. Intrauterine death and infections during pregnancy. Int J Gynaecol Obstet. 1995;51:211–218.
Tolfvenstam T, Papadogiannakis N, Norbeck O, Petersson K, Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet. 2001;357:1494–1497.
Smerdon WJ, Jones R, McLauchlin J, Reacher M. Surveillance of listeriosis in England and Wales, 1995–1999. Commun Dis Public Health. 2001;4:188–193.
Smith B, Kemp M, Ethelberg S, Schiellerup P, Bruun BG, Gerner‐Smidt P, et al. Listeria monocytogenes: maternal‐foetal infections in Denmark 1994–2005. Scand J Infect Dis. 2009;41:21–25.
Andrade JQ, Bunduki V, Curti SP, Figueiredo CA, de Oliveira MI, Zugaib M. Rubella in pregnancy: intrauterine transmission and perinatal outcome during a Brazilian epidemic. J Clin Virol. 2006;35:285–291.
Syridou G, Spanakis N, Konstantinidou A, Piperaki E, Kafetzis D, Patsouris E, et al. Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological findings. J Med Virol. 2008;80:1776–1782.
Goldenberg RL, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol. 2003;189:861–873.
Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Wariker N, Seal A, et al. Adverse pregnancy outcomes in an area where multidrug‐resistant plasmodium vivax and plasmodium falciparum infections are endemic. Clin Infect Dis. 2008;80:1776–1782.
Osman NB, Folgosa E, Gonzales C, Bergström S. Genital infections in the aetiology of late fetal death: an incident case‐ referent study. J Trop Pediatr. 1995;41:258–266.
Moyo SR, Hägerstrand I, Nyström L, Tswana SA, Blomberg J, Bergström S, et al. Stillbirths and intrauterine infection, histologic chorioamnionitis and microbiological findings. Int J Gynaecol Obstet. 1996;54:115–123.
DeSisto CL, Wallace B, Simeone RM, Polen K, Ko JY, Meaney‐Delman D, et al. Risk for Stillbirth among women with and without COVID‐19 at delivery hospitalization ‐ United States, March 2020‐September 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1640–1645. https://doi.org/10.15585/mmwr.mm7047e1
Cruz Melguizo S, de la Cruz Conty ML, Carmona Payán P, Abascal‐Saiz A, Pintando Recarte P, González Rodríguez L, et al. Pregnancy outcomes and SARS‐Cov‐2 infection: the Spanish obstetric emergency group study. Viruses. 2021;13(853). https://doi.org/10.3390/v13050853
Kumar M, Puri M, Yadav R, Biswas R, Singh M, Chaudhary V, et al. Stillbirths and the COVID‐19 pandemic: looking beyond SARS‐Cov‐2 infection. Int J Gynaecol Obstet. 2021;153:76–82. https://doi.org/10.1002/ijgo.13564
Mahajan NN, Pophalkar M, Patil S, Yewale B, Chaaithanya IK, Mahale SD, et al. Pregnancy outcomes and maternal complications during the second wave of Coronavirus disease 2019 (COVID‐19) in India. Obstet Gynecol. 2021;138:660–662.
Stock SJ, Moore E, Calvert C, Carruthers J, Denny C, Donaghy J. Pregnancy outcomes after SARS‐ Cov‐2 infection in periods dominated by Delta and Omicron variants in Scotland: a population‐based cohort study. Lancet Respir Med. 2022;10:1129–1136.
Royal College of Obstetricians and Gynaecologists. Green‐top Guideline No. 22. Anti‐D immunoglobulin for Rh prophylaxis. London: RCOG; 2002.
Lee D, Contreras M, Robson SC, Rodeck CH, Whittle MJ. Recommendations for the use of anti‐D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists. Transfus Med. 1999;9:93–97.
BCSH Blood Transfusion and Haematology Task Forces. The estimation of fetomaternal haemorrhage. Transfus Med. 1999;9:87–92.
Fox R. Preventing RhD haemolytic disease of the newborn. RhD negative women who have intrauterine death may need anti‐D immunoglobulin. BMJ. 1998;316:1164–1165.
Chitty LS. Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study. BMJ. 2014;349:g5243.
Clark‐Ganheart CA, Fries MH, Leifheit KM, Jensen TJ, Moreno‐Ruiz NL, Ye PP, et al. Use of cell‐free DNA in the investigation of intrauterine fetal demise and miscarriage. Obstet Gynecol. 2015;125:1321–1329.
Hills A, Fox R, Siassakos D. Incorrect sexing after pregnancy loss a note of caution. BJM. 2013;19:566–567.
Derom C, Vlietinck R, Derom R, Boklage C, Thiery M, Van den Berghe H. Genotyping of macerated stillborn fetuses. Am J Obstet Gynecol. 1991;164:797–800.
Korteweg FJ, Bouman K, Erwich JJ, Timmer A, Veeger NJ, Ravisé JM, et al. Cytogenetic analysis after evaluation of 750 fetal deaths: proposal for diagnostic workup. Obstet Gynecol. 2008;111:865–874.
Laury A, Sanchez‐Lara PA, Pepkowitz S, Graham JM. A study of 534 fetal pathology cases from prenatal diagnosis referrals analysed from 1989 through 2000. Am J Med Genet A. 2007;143A:3107–3120.
Reddy UM, Page GP, Saade GR, Silver RM, Thorsten VR, Parker CB, et al. NICHD Stillbirth Collaborative Research Network. Karyotype versus microarray testing for genetic abnormalities after stillbirth. N Engl J Med. 2012;367:2185–2193.
Diego‐Alvarez D, Garcia‐Hoyos M, Trujillo MJ, Gonzalez‐ Gonzalez C, Rodriguez de Alba M, Ayuso C, et al. Application of quantitative fluorescent PCR with short tandem repeat markers to the study of aneuploidies in spontaneous miscarriages. Hum Reprod. 2005;20:1235–1243.
Zou G, Zhang J, Li XW, He L, He G, Duan T. Quantitative fluorescent polymerase chain reaction to detect chromosomal anomalies in spontaneous abortion. Int J Gynaecol Obstet. 2008;103:237–240.
Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. JAMA. 2011;306:2459–2468.
Miller ES, Minturn L, Linn R, Weese‐Mayer DE, Ernst LM. Stillbirth evaluation: a stepwise assessment of placental pathology and autopsy. Am J Obstet Gynecol. 2016;214(115):e1–e6.
Ptacek I, Sebire NJ, Man JA, Brownbill P, Heazell AE. Systematic review of placental pathology reported in association with stillbirth. Placenta. 2014;35:552–562.
Man J, Hutchinson JC, Heazell AE, Ashworth M, Jeffrey I, SEbire N. Stillbirth and intrauterine fetal death: role of routine histopathological placental findings to determine cause of death. Ultrasound Obstet Gynecol. 2016;48:579–584.
Confidential Enquiry into Stillbirths and Deaths in Infancy. 8th annual report. London: Maternal and Child Health Research Consortium; 2001. Available from: http://www.cmace.org.uk/getattachment/8ce7dc4e‐6d7d‐47cc‐8cee‐7c0867941606/8th‐annualreport.aspx
HTA. Human tissue authority. Available from: https://www.hta.gov.uk/policies/post‐mortem‐model‐consent‐forms. Accessed Jan 2019
Martinek IE, Vial Y, Hohlfeld P. Management of in utero foetal death: which assessment to undertake? J Gynecol Obstet Biol Reprod (Paris). 2006;35:594–606. Article in French.
Kidron D, Bernheim J, Aviram R. Placental findings contributing to fetal death, a study of 120 stillbirths between 23 and 40 weeks gestation. Placenta. 2009;30:700–704.
Available from: https://www.england.nhs.uk/wp‐content/uploads/2013/06/e12‐perinatal‐path.pdf. Accessed 17 Aug 2022.
Shelmerdine SC, Hutchinson JC, Lewis C, Simcock IC, Sekar T, Sebire NJ, et al. A pragmatic evidence‐based approach to post‐mortem perinatal imaging. Insights Imaging. 2021;12(1):101.
Thayyil S, Seibre NJ, Chitty LS. Post –mortem MRI versus conventional autopsy in fetusus and children: a prospective validation study. Lancet. 2013;382:223–233.
Shelmerdine S, Langdan D, Seibre NJ, Arthurs O. Diagnostic accuracy of post‐mortem ultrasound (PMUS); a systematic review. BMJ Paediatr Open. 2019;3:e00056.
Arthurs OJ, Calder AD, Kiho L, Taylor AM, Sebire NJ. Routine perinatal and paediatric post‐mortem radiography: detection rates and implications for practice. Pediatr Radiol. 2014;44:252–257.
Shelmerdine SC, Hutchinson JC, Ward L, Sekar T, Ashworth MT, Levine S, et al. Feasibility of INTACT (INcisionless TArgeted Core Tissue) biopsy procedure for perinatal autopsy. Ultrasound Obstet Gynecol. 2020;55(5):667–675.
Cannie M, Votino C, Moerman P, Vanheste R, Segers V, Van Berkel K, et al. Acceptance, reliability and confidence of diagnosis of fetal and neonatal virtuopsy compared with conventional autopsy: a prospective study. Ultrasound Obstet Gynecol. 2012;39:659–665.
Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40:467–474.
Biankin SA, Arbuckle SM, Graf NS. Autopsy findings in a series of five cases of fetomaternal haemorrhages. Pathology. 2003;35:319–324.
Thorp JM Jr, Katz VL, Fowler LJ, Kurtzman JT, Bowes WA Jr. Fetal death from chlamydial infection across intact amniotic membranes. Am J Obstet Gynecol. 1989;161:1245–1246.
Jain A, Nag VL, Goel MM, Chandrawati, Chaturvedi UC. Adverse foetal outcome in specific IgM positive Chlamydia trachomatis infection in pregnancy. Indian J Med Res. 1991;94:420–423.
Benedetto C, Tibaldi C, Marozio L, Marini S, Masuelli G, Pelissetto S, et al. Cervicovaginal infections during pregnancy: epidemiological and microbiological aspects. J Matern Fetal Neonatal Med. 2004;16(Suppl 2):9–12.
Blackwell S, Romero R, Chaiworapongsa T, Kim YM, Bujold E, Espinoza J, et al. Maternal and fetal inflammatory responses in unexplained fetal death. J Matern Fetal Neonatal Med. 2003;14:151–157.
Aberg A, Rydhström H, Källén B, Källén K. Impaired glucose tolerance during pregnancy is associated with increased fetal mortality in preceding sibs. Acta Obstet Gynecol Scand. 1997;76:212–217.
Engel PJ, Smith R, Brinsmead MW, Bowe SJ, Clifton VL. Male sex and pre‐existing diabetes are independent risk factors for stillbirth. Aust N Z J Obstet Gynaecol. 2008;48:375–383.
Günter HH, Scharf A, Hertel H, Hillemanns P, Wenzlaff P, Maul H. Perinatal morbidity in pregnancies of women with preconceptional and gestational diabetes mellitus in comparison with pregnancies of non‐diabetic women. Results of the perinatal registry of Lower Saxony, Germany. Z Geburtshilfe Neonatol. 2006;210:200–207. Article in German.
Keshavarz M, Cheung NW, Babaee GR, Moghadam HK, Ajami ME, Shariati M. Gestational diabetes in Iran: incidence, risk factors and pregnancy outcomes. Diabetes Res Clin Pract. 2005;69:279–286.
Maternity care during the COVID‐19 pandemic. 2020. Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/2020‐12‐09‐guidance‐for‐maternal‐medicine‐services‐in‐the‐coronavirus‐covid‐19‐pandemic.pdf. Accessed 7 Apr 2021
Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000;7:127–746.
Kist WJ, Janssen NG, Kalk JJ, Hague WM, Dekker GA, de Vries JI. Thrombophilias and adverse pregnancy outcome – A confounded problem! Thromb Haemost. 2008;99:77–85.
Gonen R, Lavi N, Attias D, Schliamser L, Borochowitz Z, Toubi E, et al. Absence of association of inherited thrombophilia with unexplained third trimester intrauterine fetal death. Am J Obstet Gynecol. 2005;192:742–746.
Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol. 2002;101:6–14.
Wikman A, Edner A, Gryfelt G, Jonsson B, Henter JI. Fetal hemolytic anemia and intrauterine death caused by anti‐M immunization. Transfusion. 2007;47:911–917.
Cannon M, Pierce R, Taber EB, Schucker J. Fatal hydrops fetalis caused by anti‐D in a mother with partial D. Obstet Gynecol. 2003;102:1143–1145.
Howard H, Martlew V, McFadyen I, Clarke C, Duguid J, Bromilow I, et al. Consequences for fetus and neonate of maternal red cell allo‐immunisation. Arch Dis Child Fetal Neonatal Ed. 1998;78:F62–F66.
Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, et al. Maternal anti‐Ro and anti‐La antibody associated endocardial fibroelastosis. Circulation. 2002;105:843–848.
Kjeldsen‐Kragh J, Killie MK, Tomter G, Golebiowska E, Randen I, Hauge R, et al. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood. 2007;110:833–839.
Pauli RM, Reiser CA. Wisconsin stillbirth service program: II. Analysis of diagnoses and diagnostic categories in the first 1,000 referrals. Am J Med Genet. 1994;50:135–133.
Tsenghi C, Metaxotou‐Stavridaki C, Strataki‐Benetou M, Kalpini‐ Mavrou A, Matsaniotis N. Chromosome studies in couples with repeated spontaneous abortions. Obstet Gynecol. 1976;47:463–468.
Sikkema‐Raddatz B, Bouman K, Verschuuren‐Bemelmans CC, Stoepker M, Mantingh A, Beekhuis JR, et al. Four years’ cytogenetic experience with the culture of chorionic villi. Prenat Diagn. 2000;20:950–955.
Lutiger B, Graham K, Einarson TR, Koren G. Relationship between gestational cocaine use and pregnancy outcome: a meta‐analysis. Teratology. 1991;44:405–414.
Thein AT, Abdel‐Fattah SA, Kyle PM, Soothill PW. An assessment of the use of interphase FISH with chromosome specific probes as an alternative to cytogenetics in prenatal diagnosis. Prenat Diagn. 2000;20:275–280.
Smith A, Bannatyne P, Russell P, Ellwood D, den Dulk G. Cytogenetic studies in perinatal death. Aust N Z J Obstet Gynaecol. 1990;30:206–210.
Tabet AC, Aboura A, Dauge MC, Audibert F, Coulomb A, Batallan A, et al. Cytogenetic analysis of trophoblasts by comparative genomic hybridization in embryo‐fetal development anomalies. Prenat Diagn. 2001;21:613–618.
Saal HM, Rodis J, Weinbaum PJ, DiMaggio R, Landrey TM. Cytogenetic evaluation of fetal death: the role of amniocentesis. Obstet Gynecol. 1987;70:601–603.
Khare M, Howarth E, Sadler J, Healey K, Konje JC. A comparison of prenatal versus postnatal karyotyping for the investigation of intrauterine fetal death after the first trimester of pregnancy. Prenat Diagn. 2005;25:1192–1195.
Heazell AE, Martindale EA. Can post‐mortem examination of the placenta help determine the cause of stillbirth? J Obstet Gynaecol. 2009;29:225–228.
Heazell AE, Siassakos D, Blencowe H, Burden C, Bhutta ZA, Cacciatore J, et al. Stillbirths: economic and psychosocial consequences. Lancet. 2016;387:604–616.
Burden C, Bradley S, Storey C, Ellis A, Heazell AE, Downe S, et al. From grief, guilt pain and stigma to hope and pride ‐ a systematic review and meta‐analysis of mixed‐method research of the psychosocial impact of stillbirth. BMC Pregnancy Childbirth. 2016;16:9.
Schaap AH, Wolf H, Bruinse HW, Barkhof‐van de Lande S, Treffers PE. Long‐term impact of perinatal bereavement. Comparison of grief reactions after intrauterine versus neonatal death. Eur J Obstet Gynecol Reprod Biol. 1997;75:161–167.
Weng SC, Chang JC, Yeh MK, Wang SM, Lee CS, Chen YH. Do stillbirth, miscarriage, and termination of pregnancy increase risks of attempted and completed suicide within a year? A population‐based nested case‐control study. BJOG. 2018;125:983–990.
Peel E. Pregnancy loss in lesbian and bisexual women: an online survey of experiences. Hum Reprod. 2010;25:721–727.
Harper M, O’Connor RC, O’Carroll RE. Increased mortality in parents bereaved in the first year of their child's life. BMJ Support Palliat Care. 2011;1:306–309.
Gold KJ, Sen A, Hayward RA. Marriage and cohabitation outcomes after pregnancy loss. Pediatrics. 2010;125:e1202–e1207.
Huberty JL, Matthews J, Leiferman J, Hermer J, Cacciatore J. When a baby dies: a systematic review of experimental interventions for women after stillbirth. Reprod Sci. 2017;24:967–975.
Bakhbakhi D, Siassakos D, Davies A, Merriel A, Barnard K, Stead E, et al. Interventions, outcomes and outcome measurement instruments in stillbirth care research: a systematic review to inform the development of a core outcome set. BJOG. 2023;130:560–576.
Simpson C, Lee P, Lionel J. The effect of bereavement counseling on women with psychological problems associated with late pregnancy loss. J Asian Midwives. 2015;2:5–21.
Rogers J, Spink M, Magrill A, Burgess K, Agius M. Evaluation of a specialised counselling service for perinatal bereavement. Psychiatr Danub. 2015;27(Suppl 1):S482–S485.
Navidian A, Saravani Z. Impact of cognitive behavioral‐based counseling on grief symptoms severity in mothers after stillbirth. Iran J Psychiatry Behav Sci. 2018;12:650–654.
Cacciatore J. ‘She used his name’: provider trait mindfulness in perinatal death counselling. Estud Psicol. 2017;38:639–666.
Huberty J, Sullivan M, Green J, Kurka J, Leiferman J, Gold K, et al. Online yoga to reduce post‐traumatic stress in women who have experienced stillbirth: a randomized control feasibility trial. BMC Complement Med Ther. 2020;20:173.
Hsu MT, Tseng YF, Banks JM, Kuo LL. Interpretations of stillbirth. J Adv Nurs. 2004;47:408–416.
DeFrain J. Learning about grief from normal families: SIDS, stillbirth, and miscarriage. J Marital Fam Ther. 1991;17:215–232.
Dowden S. Young children's experiences of sibling death. J Pediatr Nurs. 1995;10:72–79.
Appleton R, Gibson B, Hey E. The loss of a baby at birth: the role of the bereavement officer. Br J Obstet Gynaecol. 1993;100:51–54.
Petals. Available from: https://petalscharity.org/wp‐content/uploads/Petals‐information‐flier.pdf
Crawley R, Lomax S, Ayers S. Recovering from stillbirth: the effects of making and sharing memories on maternal mental health. J Reprod Infant Psychol. 2013;3:195–207.
Koopmans L, Wilson T, Cacciatore J, Flenady V. Support for mothers, fathers and families after perinatal death. Cochrane Database Syst Rev. 2013;2013(6):CD000452.
Hennegan JM, Henderson J, Redshaw M. Contact with the baby following stillbirth and parental mental health and well‐being: a systematic review. BMJ Open. 2015;5(11):e008616.
Redshaw M, Hennegan JM, Henderson J. Impact of holding the baby following stillbirth on maternal mental health and well‐being: findings from a national survey. BMJ Open. 2016;1:6.
Kingdon C, Givens JL, O’Donnell E, Turner M. Seeing and holding baby: systematic review of clinical management and parental outcomes after stillbirth. Birth. 2015;42:206.
Erlandsson K, Warland J, Cacciatore J, Rådestad I. Seeing and holding a stillborn baby: mothers’ feelings in relation to how their babies were presented to them after birth‐‐findings from an online questionnaire. Midwifery. 2013;29:246–250.
Royal College of Obstetricians and Gynaecologists. Good Practice Guideline No. 4. Registration of stillbirths and certification for pregnancy loss before 24 weeks of gestation. London: RCOG; 2005.
Higgins LE, Heazell AEP, Whitworth MK. Persistent inaccuracies in completion of medical certificates of stillbirth: a cross‐sectional study. Paediatr Perinat Epidemiol. 2018;32:474–481.
Siassakos D. INSPIRE, unpublished.
Trulsson O, Rådestad I. The silent child – mothers’ experiences before, during, and after stillbirth. Birth. 2004;31:189–195.
Scottish Government. Cremation statutory forms. Available from: https://www.gov.scot/publications/cremation‐statutory‐forms/. Accessed Feb 2020
Guidance on death, stillbirth and cremation certification. Available from: http://www.ihrdni.org/315‐008‐1.pdf. Accessed Feb 2020
Cremation codes of practice guidance recommendations and advice. Available from: https://www.cremation.org.uk/cremation‐codes‐of‐practice. Accessed Jan 2024
Regan AK, Gissler M, Magnus MC, Håberg SE, Ball S, Malacova E, et al. Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study. Lancet. 2019;393:1527–1535.
Conde‐Agudelo A, Rosas‐Bermúdez A, Kafury‐Goeta AC. Birth spacing and risk of adverse perinatal outcomes: a meta‐analysis. JAMA. 2006;295:1809–1823.
Wendt A, Gibbs CM, Peters S, Hogue CJ. Impact of increasing inter‐pregnancy interval on maternal and infant health. Paediatr Perinat Epidemiol. 2012;26(Suppl 1):239–258.
Nuzum D, Meaney S, O’Donoghue K. The impact of stillbirth on consultant obstetrician gynaecologists: a qualitative study. BJOG. 2014;121:1020–1028.
Gandino G, Bernaudo A, Di Fini G, Vanni I, Veglia F. Healthcare professionals’ experiences of perinatal loss: a systematic review. J Health Psychol. 2019;24:65–78.
Atkins B, Moatti Z, Siassakos D. Training the carers: an analysis of multidisciplinary perinatal bereavement care training in the UK. Abstract; International Stillbirth Alliance Conference 2022.
Burden C, Bakhbakhi D, Heazell AE, Lynch M, Timlin L, Bevan C, et al. Parents’ Active Role and ENgagement in The review of their Stillbirth/perinatal death 2 (PARENTS 2) study: a mixed‐methods study of implementation. BMJ Open. 2021;11:e044563.
Bakhbakhi D, Siassakos D, Lynch M, Timlin L, Storey C, Heazell A, et al. PARENTS 2 Study: consensus report for parental engagement in the perinatal mortality review process. Ultrasound Obstet Gynecol. 2019;54:215–224.
PMRT parents engagement materials. Available from: https://www.npeu.ox.ac.uk/pmrt/parent‐engagement‐materials. Accessed Feb 2020
Mills TA, Ricklesford C, Heazell AE, Cooke A, Lavender T. Marvellous to mediocre: findings of national survey of UK practice and provision of care in pregnancies after stillbirth or neonatal death. BMC Pregnancy Childbirth. 2016;16:101.
Wojcieszek AM, Boyle FM, Belizán JM, Cassidy J, Cassidy P, Erwich J, et al. Care in subsequent pregnancies following stillbirth: an international survey of parents. BJOG. 2018b;125:193–201.
Wojcieszek AM, Shepherd E, Middleton P, Lassi ZS, Wilson T, Murphy MM, et al. Care prior to and during subsequent pregnancies following stillbirth for improving outcomes. Cochrane Database Syst Rev. 2018c;12:CD012203.
Mills TA, Ricklesford C, Cooke A, Heazell AE, Whitworth M, Lavender T. Parents’ experiences and expectations of care in pregnancy after stillbirth or neonatal death: a metasynthesis. BJOG. 2014;121:943–950.
Ladhani NNN, Fockler ME, Stephens L, Barrett JFR, Heazell AEP. No. 369‐Management of pregnancy subsequent to stillbirth. J Obstet Gynaecol Can. 2018;40:1669–1683.
Meredith P, Wilson T, Branjerdporn G, Strong J, Desha L. “Not just a normal mum”: a qualitative investigation of a support service for women who are pregnant subsequent to perinatal loss. BMC Pregnancy Childbirth. 2017;17:6.
Yerlikaya G, Akolekar R, McPherson K, Syngelaki A, Nicolaides KH. Prediction of stillbirth from maternal demographic and pregnancy characteristics. Ultrasound Obstet Gynecol. 2016;48:607–612.
Jacob L, Kostev K, Kalder M. Risk of stillbirth in pregnant women with obesity in the United Kingdom. Obes Res Clin Pract. 2016;10:574–579.
Bjørnholt SM, Leite M, Albieri V, Kjaer SK, Jensen A. Maternal smoking during pregnancy and risk of stillbirth: results from a nationwide Danish register based cohort study. Acta Obstet Gynecol Scand. 2016;95:1305–1312.
Pineles BL, Hsu S, Park E, Samet JM. Systematic review and meta‐analyses of perinatal death and maternal exposure to tobacco smoke during pregnancy. Am J Epidemiol. 2016;184:87–97.
Lamminpaa R, Vehvilainen‐Julkunen K, Gissler M, Selander T, Heinonen S. Pregnancy outcomes of overweight and obese women aged 35 years or older – a registry‐based study in Finland. Obes Res Clin Pract. 2016;10:133.
Getahun D, Ananth CV, Kinzler WL. Risk factors for antepartum and intrapartum stillbirth: a population‐based study. Am J Obstet Gynecol. 2007;196:499–507.
Räisänen S, Hogue CJR, Laine K, Kramer MR, Gissler M, Heinonen S. A population‐based study of the effect of pregnancy history on risk of stillbirth. Int J Gynaecol Obstet. 2018;140:73–80.
Stacey T, Tennant P, McCowan L, Mitchell EA, Budd J, Li M, et al. Gestational diabetes and the risk of late stillbirth: a case‐control study from England, UK. BJOG. 2019;126:973–982.
Bourne I, Sebire N, Kindinger L, Whitten SM, Battaglino C. Abnormal placental villous maturity and dysregulated glucose metabolism: implications for stillbirth prevention. J Perinat Med. 2022;1(50):763–768.
Poon LCY, Volpe N, Muto B, Syngelaki A, Nicolaides KH. Birthweight with gestation and maternal characteristics in live births and stillbirths. Fetal Diagn Ther. 2012;32:156–165.
Poon LCY, Tan MY, Yerlikaya G, Syngelaki A, Nicolaides KH. Birth weight in live births and stillbirths. Ultrasound Obstet Gynecol. 2016;48:602–606.
Malacova E, Regan A, Nassar N, Raynes‐Greenow C, Leonard H, Srinivasjois R, et al. Risk of stillbirth, preterm delivery, and fetal growth restriction following exposure in a previous birth: systematic review and meta‐analysis. BJOG. 2018;125:183–192.
Khalil A, Morales‐Rosellõ J, Townsend R, Morlando M, Papageorghiou A, Bhide A, et al. Value of third‐trimester cerebroplacental ratio and uterine artery Doppler indices as predictors of stillbirth and perinatal loss. Ultrasound Obstet Gynecol. 2016;47:74–80.
Kumar M, Singh S, Sharma K, Singh R, Ravi V, Bhattacharya J. Adverse fetal outcome: is first trimester ultrasound and Doppler better predictor than biomarkers? J Matern Fetal Neonatal Med. 2017;30:1410–1416.
Moraitis AA, Wood AM, Fleming M, Smith GCS. Birth weight percentile and the risk of term perinatal death. Obstet Gynecol. 2014;124:274–283.
García B, Llurba E, Valle L, Gómez‐Roig MD, Juan M, Pérez‐Matos C, et al. Do knowledge of uterine artery resistance in the second trimester and targeted surveillance improve maternal and perinatal outcome? UTOPIA study: a randomized controlled trial. Ultrasound Obstet Gynecol. 2016;47:680–689.
Allen RE, Morlando M, Thilaganathan B, Zamora J, Khan KS, Thangaratinam S, et al. Predictive accuracy of second‐trimester uterine artery Doppler indices for stillbirth: a systematic review and meta‐analysis. Ultrasound Obstet Gynecol. 2016;47:22–27.
Bilardo CM, Hecher K, Visser GHA, Papageorghiou AT, Marlow N, Thilaganathan B, et al. Severe fetal growth restriction at 26–32 weeks: key messages from the TRUFFLE study. Ultrasound Obstet Gynecol. 2017;50:285–290.
O’Leary J. The trauma of ultrasound during a pregnancy following perinatal loss. J Loss Trauma. 2006;10:183–204.
Grobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, et al. Labor induction versus expectant management in low‐risk nulliparous women. N Engl J Med. 2018;379:513–523.
Stock SJ, Ferguson E, Duffy A, Ford I, Chalmers J, Norman JE. Outcomes of elective induction of labour compared with expectant management: population based study. BMJ. 2012;344:e2838.
Walker KF, Bugg GJ, Macpherson M, McCormick C, Grace N, Wildsmith C, et al. Randomized trial of labor induction in women 35 years of age or older. N Engl J Med. 2016;374:813–822.
Gebhardt S, Oberholzer L. Elective delivery at term after a previous unexplained intra‐uterine fetal death: audit of delivery outcome at Tygerberg Hospital, South Africa. PLoS One. 2015;10:e0130254.
Crandon AJ, Isherwood DM. Effect of aspirin on incidence of pre‐eclampsia. Lancet. 1979;1:1356.
Duley L, Henderson‐Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre‐eclampsia and its complications. Cochrane Database Syst Rev. 2007;18:CD004659.
Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218:287–293.
Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta‐analysis. Am J Obstet Gynecol. 2017;216:110–120. https://doi.org/10.1016/j.ajog.2016.09.076
Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm Preeclampsia. N Engl J Med. 2017;377:613–622. https://doi.org/10.1056/NEJMoa1704559
Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226:S1108–S1119. https://doi.org/10.1016/j.ajog.2020.08.045
Wright D, Poon LC, Rolnik DL, Syngelaki A, Delgado JL, Vojtassakova D, et al. Aspirin for evidence‐based Preeclampsia prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm Preeclampsia. Am J Obstet Gynecol. 2017;217:685. https://doi.org/10.1016/j.ajog.2017.08.110
Saving babies lives version 3. Available from: https://www.england.nhs.uk/publication/saving‐babies‐lives‐version‐three/. Accessed 21 Jun 2023
Rodger M, Gris J, Vries J, Mayhew A. Low–molecular weight heparin and recurrent placenta–mediated pregnancy complications: a meta‐analysis of individual patient data from randomised controlled trials. Lancet. 2016;16:31139–31134.
Safer maternity care. 2016. Available from: https://www.gov.uk/government/publications/safer‐maternity‐care
Bakhbakhi D, Fraser A, Siasakos D, Hinton L, Davies A, Merriel A, et al. Protocol for the development of a core outcome set for stillbirth care research (iCHOOSE Study). BMJ Open. 2022;12(2):e056629.